placeCanada – English


We developed the Veriset™ hemostatic patch based on six years of scientific research and development.


Fast and reliable

  • 75% of patients achieve hemostasis in approximately 1 minute1
  • Hold for only 30 seconds([FOOTNOTE=Based on Veriset™ hemostatic patch instructions for use and product specifications. 2014.],[ANCHOR=],[LINK=])

Increased patient safety

  • 100% free of human or animal components, eliminating risk of viral transmission2


  • Effective in cases of inhibited coagulation, independent of clotting ability shown in a pre-clinical study([FOOTNOTE=Sponsored preclinical study assessing CV and PV models on animals with inhibited platelet activity (heparin, aspirin, Plavix™*). 2010.
  • Significantly superior performance compared to TachoSil™*1,([FOOTNOTE=Based on internal test study #COVEUCV0140-CSR, Study to compare the Veriset™ hemostatic patch to TachoSil™* as an adjunct to hemostasis in subjects undergoing cardiovascular surgery. March 2014. Data on file.],[ANCHOR=],[LINK=])


  • Can be used in both open and laparoscopic procedures2
  • Easily passes through trocar([FOOTNOTE=Based on internal study #TR1478, Evaluating Veriset™ hemostatic patch after laparoscopic liver resection in a porcine model. 2013.],[ANCHOR=],[LINK=])